106 related articles for article (PubMed ID: 1319829)
1. Gastrin-releasing peptide: in vivo and in vitro growth effects on an acinar pancreatic carcinoma.
Hajri A; Balboni G; Koenig M; Garaud JC; Damgé C
Cancer Res; 1992 Jul; 52(13):3726-32. PubMed ID: 1319829
[TBL] [Abstract][Full Text] [Related]
2. Specific binding and growth effects of bombesin-related peptides on mouse colon cancer cells in vitro.
Narayan S; Guo YS; Townsend CM; Singh P
Cancer Res; 1990 Nov; 50(21):6772-8. PubMed ID: 2208141
[TBL] [Abstract][Full Text] [Related]
3. A potent bombesin receptor antagonist inhibits bombesin-stimulated growth of mouse colon cancer cells in vitro: absence of autocrine effects.
Narayan S; Spindel ER; Rubin NH; Singh P
Cell Growth Differ; 1992 Feb; 3(2):111-8. PubMed ID: 1323998
[TBL] [Abstract][Full Text] [Related]
4. Gastrin-releasing peptide receptor in rat brain membranes: specific binding and stimulation of phosphoinositide breakdown.
Hollingsworth EB
Mol Pharmacol; 1989 May; 35(5):689-94. PubMed ID: 2542758
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer.
Pinski J; Reile H; Halmos G; Groot K; Schally AV
Cancer Res; 1994 Jan; 54(1):169-74. PubMed ID: 7903203
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of bombesin receptor antagonist RC-3095 on the growth of human pancreatic cancer cells in vivo and in vitro.
Qin Y; Ertl T; Cai RZ; Halmos G; Schally AV
Cancer Res; 1994 Feb; 54(4):1035-41. PubMed ID: 8313359
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin analogues and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of human glioblastomas in vitro and in vivo.
Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K
Cancer Res; 1994 Nov; 54(22):5895-901. PubMed ID: 7954420
[TBL] [Abstract][Full Text] [Related]
8. Effect of the gastrin-releasing peptide antagonist BIM 26226 and lanreotide on an acinar pancreatic carcinoma.
Damgé C; Hajri A
Eur J Pharmacol; 1998 Apr; 347(1):77-86. PubMed ID: 9650851
[TBL] [Abstract][Full Text] [Related]
9. Antitumoral activity of bombesin analogues on small cell lung cancer xenografts: relationship with bombesin receptor expression.
Thomas F; Arvelo F; Antoine E; Jacrot M; Poupon MF
Cancer Res; 1992 Sep; 52(18):4872-7. PubMed ID: 1325285
[TBL] [Abstract][Full Text] [Related]
10. [Psi 13,14] bombesin analogues inhibit growth of small cell lung cancerin vitro and in vivo.
Mahmoud S; Staley J; Taylor J; Bogden A; Moreau JP; Coy D; Avis I; Cuttitta F; Mulshine JL; Moody TW
Cancer Res; 1991 Apr; 51(7):1798-802. PubMed ID: 1848479
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of bombesin/gastrin-releasing peptide antagonist RC-3095 and high dose of somatostatin analogue RC-160 on nitrosamine-induced pancreatic cancers in hamsters.
Szepeshazi K; Schally AV; Cai RZ; Radulovic S; Milovanovic S; Szoke B
Cancer Res; 1991 Nov; 51(21):5980-6. PubMed ID: 1682039
[TBL] [Abstract][Full Text] [Related]
12. Bombesin receptors in a human duodenal tumor cell line: binding properties and function.
Williams BY; Schonbrunn A
Cancer Res; 1994 Feb; 54(3):818-24. PubMed ID: 8306345
[TBL] [Abstract][Full Text] [Related]
13. Neuromedin B receptors retain functional expression when transfected into BALB 3T3 fibroblasts: analysis of binding, kinetics, stoichiometry, modulation by guanine nucleotide-binding proteins, and signal transduction and comparison with natively expressed receptors.
Benya RV; Wada E; Battey JF; Fathi Z; Wang LH; Mantey SA; Coy DH; Jensen RT
Mol Pharmacol; 1992 Dec; 42(6):1058-68. PubMed ID: 1336112
[TBL] [Abstract][Full Text] [Related]
14. The effects of antagonists of receptors for gastrin, cholecystokinin and bombesin on growth of gastroduodenal mucosa and pancreas.
Dembiński A; Warzecha Z; Konturek SJ; Cai RZ; Schally AV
J Physiol Pharmacol; 1991 Jun; 42(2):195-209. PubMed ID: 1664265
[TBL] [Abstract][Full Text] [Related]
15. Nonconstitutive expression of the gastrin-releasing peptide autocrine growth system in human small cell lung carcinoma NCI-H345 cells.
Aguayo SM; Miller Y; Boose D; Holley M; Portanova LB; Schuyler KD; Kane MA
Cell Growth Differ; 1996 May; 7(5):563-72. PubMed ID: 8732666
[TBL] [Abstract][Full Text] [Related]
16. Effects of bombesin antagonists on the growth of small cell lung cancer cells in vitro.
Layton JE; Scanlon DB; Soveny C; Morstyn G
Cancer Res; 1988 Sep; 48(17):4783-9. PubMed ID: 2457430
[TBL] [Abstract][Full Text] [Related]
17. Effects of bombesin on human small cell lung cancer cells: evidence for a subset of bombesin non-responsive cell lines.
Kado-Fong H; Malfroy B
J Cell Biochem; 1989 Aug; 40(4):431-7. PubMed ID: 2550492
[TBL] [Abstract][Full Text] [Related]
18. Characterization of bombesin/gastrin-releasing peptide receptors in human breast cancer and their relationship to steroid receptor expression.
Halmos G; Wittliff JL; Schally AV
Cancer Res; 1995 Jan; 55(2):280-7. PubMed ID: 7812958
[TBL] [Abstract][Full Text] [Related]
19. Human glioblastoma cell lines have neuropeptide receptors for bombesin/gastrin-releasing peptide.
Moody TW; Mahmoud S; Staley J; Naldini L; Cirillo D; South V; Felder S; Kris R
J Mol Neurosci; 1989; 1(4):235-42. PubMed ID: 2561955
[TBL] [Abstract][Full Text] [Related]
20. Internalization of the gastrin-releasing peptide receptor is mediated by both phospholipase C-dependent and -independent processes.
Benya RV; Akeson M; Mrozinski J; Jensen RT; Battey JF
Mol Pharmacol; 1994 Sep; 46(3):495-501. PubMed ID: 7935330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]